Omkar Pharmachem share news, announcements and annual reports
BSE: 532167Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹6.25.
30 Oct: open ₹6.25, high ₹6.25, low ₹6.25
- Under BSE's graded surveillance, stage II, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.30 Cr3,900th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 73.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 25
Omkar Pharmachem has 405 announcements on record, routine notices left out; none in the 30 days to 2 Nov 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Omkar Pharmachem quarterly results
The board met on 13 Aug 2026 to consider quarterly results
Notice filed 6 Aug 2026
Omkar Pharmachem annual reports, presentations and earnings calls
The company's own documents, latest first.Omkar Pharmachem financials, year by year
Annual reports28
- Annual report, year to Mar 20262 Sep 2026
- Annual report, year to Mar 202529 Aug 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 20234 Sep 2023
- Annual report, year to Mar 20222 Sep 2022
23 earlier reports
- Annual report, year to Mar 20213 Sep 2021
- Annual report, year to Mar 20202 Sep 2020
- Annual report, year to Mar 20192 Sep 2019
- Annual report, year to Mar 20189 Oct 2018
- Annual report, year to Mar 20179 Oct 2017
- Annual report, year to Mar 201610 Oct 2016
- Annual report, year to Mar 2015Filing day not known
- Annual report, year to Mar 2014Filing day not known
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 20115 Nov 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
Omkar Pharmachem share news and announcements
Newest first. Page 1 of 9.
Oct 2026
Sep 2026
2 Sep · Meeting
Aug 2026
31 Aug · Board meeting
6 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
May 2026
21 May · Board meeting
Meeting on 30 May 2026: audited results19 May · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Change In Name Of Managing Director Of The Company
Feb 2026
16 Feb · Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015
4 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
27 Jan · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.
Nov 2025
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
Aug 2025
27 Aug · Board meeting
5 Aug · Board meeting
Meeting on 13 Aug 2025: quarterly results
Jun 2025
May 2025
21 May · Board meeting
Meeting on 29 May 2025: audited results
Feb 2025
6 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Jan 2025
Dec 2024
Nov 2024
5 Nov · Board meeting
Meeting on 12 Nov 2024: quarterly results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 30 May 2025Board or managers changeddown 0.50%−0.6 pts vs Nifty 500market median 0.0% · five sessions −3.5% (−5.9 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 30 Dec 2024Board or managers changed–market median 0.0% · volume 1.0× usual · The announcement